BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Foghorn Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-30 4:51 pm Purchase |
2024-05-20 | 13G | Foghorn Therapeutics Inc. FHTX |
BIOTECHNOLOGY VALUE FUND L P | 5,552,341 9.990% |
5,552,341 (New Position) |
Filing |